Experimental Hematology Group - VHIO

VHIO’s Experimental Hematology Group conducts translational, pre-clinical and clinical research on hematological neoplasms of both lymphoid and myeloid origin. Our research team is composed of hematologists and biological scientists who work closely together to design, conduct and lead our programs.

Mivavotinib for Relapsed/Refractory B-cell Lymphoma (Updated

Tumor Biomarkers Group - VHIO

The international project LEGACy concludes with advances in the

Conservation of copy number profiles during engraftment and

Tumor Immunology & Immunotherapy Group - VHIO

Harmonizing PD-L1 testing in metastatic triple negative breast

Scientific Coordination Area - VHIO

Genome Engineering Group - VHIO

Cristina HERNANDEZ PhD Student in Experimental Hematology Group

PDF) Microenvironment regulates the expression of MIR-21 and tumor

Experimental Hematology, Journal

VHIO and Catalan Blood & Tissue Bank trial to assess novel T-cell